Trial
NCT02170012
A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Healthy Elderly
Intervention
PF-06743649
Why stopped
The study was prematurely terminated on 17th December 2014 due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-17